Metropolis Healthcare (NSE:METROPOLIS) EPS (Basic): ₹9.18 (TTM As of Mar. 2026)


NSE:METROPOLIS Metropolis Healthcare Ltd NSE:METROPOLIS
91 GF Score
Price ₹543.35
GF Value ₹584.94
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Metropolis Healthcare EPS (Basic)?

Metropolis Healthcare NSE:METROPOLIS -1.78% 91 EPS (Basic) is ₹9.18 as of Mar. 2026. GuruFocus rates NSE:METROPOLIS with a GF Score™ of 91/100 and a GF Value™ of ₹584.94 (Fairly Valued). The stock has 4 warning signs investors should review.

Metropolis Healthcare's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹2.46. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.18.

Metropolis Healthcare's EPS (Diluted) for the three months ended in Mar. 2026 was ₹2.46. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.14.

Metropolis Healthcare's EPS without NRI for the three months ended in Mar. 2026 was ₹2.46. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 9.46.

During the past 12 months, Metropolis Healthcare's average EPS without NRIGrowth Rate was 35.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Metropolis Healthcare's highest 3-Year average EPS without NRI Growth Rate was 20.10% per year. The lowest was -11.60% per year. And the median was 11.20% per year.

Metropolis Healthcare  (NSE:METROPOLIS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Metropolis Healthcare EPS (Basic) Related Terms

Metropolis Healthcare EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Metropolis Healthcare's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metropolis Healthcare EPS (Basic) Chart

Metropolis Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.47 6.98 6.24 7.07 9.19

Metropolis Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 2.18 2.54 2.00 2.46
NSE:METROPOLIS
91GF Score
Metropolis Healthcare Ltd NSE:METROPOLIS
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metropolis Healthcare EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Metropolis Healthcare's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1900.174-0)/206.765
=9.19

Metropolis Healthcare's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(509.03-0)/206.923
=2.46

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹9.18 mean?
Metropolis Healthcare (NSE:METROPOLIS) has a EPS (Basic) of ₹9.18 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Metropolis Healthcare and its competitors.
Is Metropolis Healthcare's EPS (Basic) too high?
Metropolis Healthcare's current EPS (Basic) is ₹9.18. Overall, Metropolis Healthcare has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metropolis Healthcare's EPS (Basic) compare to TMO and DHR?
Metropolis Healthcare's EPS (Basic) of ₹9.18 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Metropolis Healthcare and its competitors. Metropolis Healthcare's current EPS (Basic) is ₹9.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metropolis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Metropolis Healthcare (NSE:METROPOLIS) is currently considered Fairly Valued. The stock's GF Value™ is ₹584.94, compared to a current price of ₹543.35 — trading 7.1% below its estimated fair value. The current EPS (Basic) is ₹9.18. Metropolis Healthcare's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Metropolis Healthcare (NSE:METROPOLIS), the current EPS (Basic) is ₹9.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metropolis Healthcare (NSE:METROPOLIS) Overvalued in 2026?

Based on GuruFocus' analysis, Metropolis Healthcare stock appears to be undervalued. The current stock price of ₹543.35 is trading 7.1% below its estimated GF Value™ of ₹584.94. GuruFocus considers Metropolis Healthcare to be Fairly Valued.

Key valuation signals for NSE:METROPOLIS:

  • EPS (Basic): ₹9.18
  • GF Value™: ₹584.94 vs. price of ₹543.35 (7.1% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the NSE:METROPOLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Metropolis Healthcare Business Description

Other Exchanges 542650:India
Address Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
91GF Score

Get the complete analysis for NSE:METROPOLIS

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹543.35
Price
₹584.94
GF Value